Materion (MTRN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record Q2 2024 results with value-added sales of $279.8M, adjusted EBITDA of $57.8M (20.7% margin), and adjusted EPS of $1.42, driven by aerospace, defense, semiconductor, and consumer electronics, despite softness in industrial, automotive, and energy markets.
Net sales for Q2 2024 increased 7% year-over-year to $425.9M, but net income declined 21% to $19.0M due to margin pressure and higher costs.
Secured a $150M multi-year contract for space propulsion systems, $60M in new defense orders, and announced major customer investments, including PMI's IQOS ILUMA project.
Outperformed adjusted EBITDA margin target through operational excellence, cost management, and organic growth initiatives.
Financial highlights
Q2 2024 net sales: $425.9M (+7% YoY); value-added sales: $279.8M (+4% YoY); adjusted EBITDA: $57.8M (20.7% margin, +4% YoY); adjusted EPS: $1.42 (+3% YoY); net income: $19.0M (6.8% of VA sales, -21% YoY).
Operating profit for Q2 2024 was $32.1M, down 9% year-over-year.
Cash and cash equivalents at quarter-end were $17.1M; total debt was $484.8M; net debt/TTM adjusted EBITDA: 2.2x.
Interest expense increased to $8.8M from $7.7M YoY.
Gross margin was $80.9M (29% of VA sales), down from $89.1M (33%) YoY.
Outlook and guidance
Full-year 2024 adjusted EPS guidance updated to $5.60–$5.90, a 2% increase at midpoint over prior year, with the top end lowered due to softer end-market demand.
Expect Q4 to be the strongest quarter, with sequential improvement in Q3 and further margin expansion.
Capital expenditures projected at $80M for 2024, focused on new product development and infrastructure.
Management believes liquidity is sufficient to support operations, capital needs, dividends, and strategic initiatives for at least the next twelve months.
Latest events from Materion
- Advanced materials leader expects double-digit sales growth in 2026, driven by strong demand.MTRN
Corporate presentation9 Jul 2026 - 2026 guidance targets 15% EPS growth and margin expansion, led by strong segment performance.MTRN
Q4 20259 Jul 2026 - Record sales, backlog, and segment growth drive higher adjusted EPS and strong full-year outlook.MTRN
Q1 20261 May 2026 - Proxy covers director elections, auditor ratification, executive pay, and board size amendment.MTRN
Proxy filing26 Mar 2026 - Proxy covers director elections, auditor ratification, pay, board size, and ESG oversight.MTRN
Proxy Filing12 Mar 2026 - Record adjusted EBITDA margin achieved as net income fell; full-year EPS guided at $5.20–$5.40.MTRN
Q3 202417 Jan 2026 - Record adjusted EBITDA and margin expansion achieved, with 2025 guidance signaling continued growth.MTRN
Q4 202429 Dec 2025 - Record Q1 margin and earnings growth achieved, with tariff risks closely monitored.MTRN
Q1 202523 Dec 2025 - Proxy covers director elections, new equity plan, auditor ratification, and executive pay.MTRN
Proxy Filing2 Dec 2025